medroxyprogesterone has been researched along with Carcinoma, Hepatocellular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kamiyama, T; Kawamukai, Y; Nagabuchi, E; Nakajima, Y; Ogasawara, K; Sato, N; Sato, Y; Uchino, J; Une, Y | 1 |
Abul-Hajj, YJ; Houglum, JE; Morris, HP | 1 |
2 other study(ies) available for medroxyprogesterone and Carcinoma, Hepatocellular
Article | Year |
---|---|
[A case of double cancer of gastric and hepatocellular carcinoma associated with cirrhosis treated by hepatic resection after intra-hepatic arterial infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Combined Modality Therapy; Doxorubicin; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Multiple Primary; Stomach Neoplasms; Tamoxifen | 1990 |
Steroid delta 4 -reductase activity in hepatomas of differentgrowth rates.
Topics: Animals; Carcinoma, Hepatocellular; Cell Division; Enzyme Induction; Liver; Liver Neoplasms; Male; Medroxyprogesterone; Microsomes, Liver; Neoplasms, Experimental; Oxidoreductases; Rats; Testosterone | 1974 |